Cargando…

Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes

Background and objectives: Diagnostic delay causes unfavorable outcomes among cancer patients. It has been widely analyzed in solid tumors. However, data regarding hematological malignancies diagnostic delay are scarce. We aimed to evaluate diagnostic intervals, their influencing factors, and the ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dapkevičiūtė, Austėja, Šapoka, Virginijus, Martynova, Elena, Pečeliūnas, Valdas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631661/ https://www.ncbi.nlm.nih.gov/pubmed/31163661 http://dx.doi.org/10.3390/medicina55060238

Ejemplares similares

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
por: Maneikis, Kazimieras, et al.
Publicado: (2021)

Case report: Relapsed/refractory extranodal natural killer/T-cell lymphoma nasal type with extensive central nervous system involvement
por: Dapkevičiūtė-Purlienė, Austėja, et al.
Publicado: (2023)

Patient satisfaction with primary healthcare services: are there any links with patients’ symptoms of anxiety and depression?
por: Kavalnienė, Rima, et al.
Publicado: (2018)

Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan
por: Maneikis, Kazimieras, et al.
Publicado: (2020)

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
por: Howell, Debra A, et al.
Publicado: (2013)

Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
por: Cattaneo, Chiara, et al.
Publicado: (2022)

Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation
por: Čepulytė, Rūta, et al.
Publicado: (2020)

Quality of diabetes care at the largest outpatient clinics in Vilnius
por: Visockienė, Žydrūnė, et al.
Publicado: (2016)

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death
por: Howell, Debra A, et al.
Publicado: (2013)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Haematological malignancies implications during the times of the COVID-19 pandemic
por: Papakonstantinou, Eleni, et al.
Publicado: (2021)

PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

Application of double-negative T cells in haematological malignancies: recent progress and future directions
por: Chen, Xingchi, et al.
Publicado: (2022)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Diagnostic Challenge of Necrotizing Soft Tissue Infection in a Patient With B Lymphocytic Leukemia
por: Sadauskas, Andrius, et al.
Publicado: (2020)

Evaluation of Haematological Parameters and Uric Acid in the Diagnosis of Late Onset Neonatal Sepsis
por: Yılmaz Oztorun, Zeynep
Publicado: (2023)

A Case Report and Review of the Literature of Penile Metastasis From Rectal Cancer
por: Kaminskas, Azuolas, et al.
Publicado: (2022)

HAEMATOLOGY IN DIAGNOSIS AND TREATMENT
Publicado: (1969)

Practical Hæmatological Diagnosis
Publicado: (1933)

Outcome of patients with haematological malignancy admitted to the general ICU
por: Ketchley, I, et al.
Publicado: (2008)

Expression of testicular genes in haematological malignancies
por: Lim, S H, et al.
Publicado: (1999)

Clinical use of rituximab in haematological malignancies
por: Avivi, I, et al.
Publicado: (2003)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

Breast imaging findings in haematological malignancies
por: Glazebrook, K. N., et al.
Publicado: (2014)

The hypoxia signalling pathway in haematological malignancies
por: Irigoyen, Marta, et al.
Publicado: (2017)

The Application of CAR-T Cells in Haematological Malignancies
por: Skorka, Katarzyna, et al.
Publicado: (2020)

Clinical Proteomics of Biofluids in Haematological Malignancies
por: Dunphy, Katie, et al.
Publicado: (2021)

COVID-19 in children with haematological malignancies
por: Millen, Gerard Cathal, et al.
Publicado: (2022)

Targeting hypoxia in solid and haematological malignancies
por: Harris, Bill, et al.
Publicado: (2022)

Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases
por: Metan, Gökhan, et al.
Publicado: (2013)

Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
por: Goswami, Pushpendra, et al.
Publicado: (2020)

Outcome of patients with metastatic cancer or haematological malignancy in intensive care
por: Meynaar, I, et al.
Publicado: (2009)

Predictors of outcome in patients with haematological malignancies admitted to critical care
por: Tridente, A, et al.
Publicado: (2014)

Multiple Myeloma Immunophenotype Related to Chromosomal Abnormalities Used in Risk Assessment
por: Radzevičius, Mantas, et al.
Publicado: (2022)

Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies
por: Banerji, Versha, et al.
Publicado: (2012)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_t6kdore528tvube26o8vn6f7ic